HRT Financial’s Acacia Research ACTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-53,323
Closed -$190K 2779
2025
Q2
$190K Buy
+53,323
New +$184K ﹤0.01% 2090
2024
Q4
Sell
-11,712
Closed -$54K 2355
2024
Q3
$54K Buy
+11,712
New +$57.9K ﹤0.01% 2094
2024
Q2
Sell
-28,913
Closed -$154K 2135
2024
Q1
$154K Buy
28,913
+12,790
+79% +$53.4K ﹤0.01% 1811
2023
Q4
$63K Sell
16,123
-64,768
-80% -$240K ﹤0.01% 1932
2023
Q3
$295K Buy
+80,891
New +$309K ﹤0.01% 1664
2023
Q2
Sell
-88,757
Closed -$342K 2365
2023
Q1
$342K Buy
+88,757
New +$375K ﹤0.01% 1629
2022
Q4
Sell
-17,790
Closed -$71K 2408
2022
Q3
$71K Buy
17,790
+5,712
+47% +$26.4K ﹤0.01% 2418
2022
Q2
$60K Buy
+12,078
New +$55.4K ﹤0.01% 2493
2022
Q1
Sell
-26,597
Closed -$136K 3010
2021
Q4
$136K Buy
+26,597
New +$144K ﹤0.01% 2678
2018
Q4
Sell
-14,247
Closed -$45K 574
2018
Q3
$45K Buy
+14,247
New +$53K 0.01% 379

Other funds holding ACTG

HRT Financial's ACTG Position: Q3 2025 in Review

HRT Financial sold out of Acacia Research (ACTG) in Q3 2025, closing a stake of 53,323 shares — an estimated $190K sold.

HRT Financial first reported a position in ACTG in Q3 2018 and held it in 10 quarters. The position peaked at $342K in Q1 2023. 89 funds tracked by Wall St. Rank hold ACTG as of Q3 2025.

  • HRT Financial reported no remaining Acacia Research position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 53,323 Acacia Research shares in Q3 2025, an estimated $190K.
  • HRT Financial first reported a position in Acacia Research in Q3 2018 and held it in 10 quarters.
  • HRT Financial's Acacia Research position peaked at $342K in Q1 2023.
  • 89 funds tracked by Wall St. Rank held Acacia Research as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.